Scientific Insights in a Pandemic

Agenda

Time Sessions

09:00 Welcome Professor Andrew Morris, Health Data Research UK

Opening keynote: A year of accelerated science and impact Sir Jeremy Farrar, Wellcome Trust 09:10 Plenary keynote: UK Learnings from COVID – and where now? Sir , UK Government Chief Scientific Adviser 09:20 Q&A Chair: Professor Dame Anne Johnson, University College Panellist: • Sir Patrick Vallance, UK Government Chief Scientific Adviser 09:30 UK COVID Science – the perspective of the public, the media and the NHS Fiona Fox, Science Media Centre, Chris Monk, Patient Representative, Dr Mark Toshner, Royal Papworth NHS Trust 09:50 Panel Discussion Chair: Professor Andrew Morris Health Data Research UK

www.hdruk.ac.uk | [email protected] | @HDR_UK | www.healthdatagateway.org | www.ukhealthdata.org

Join the conversation: #COVIDcorestudies

Panellists: • Fiona Fox, Science Media Centre • Chris Monk, Patient Representative • Dr Mark Toshner, Royal Papworth NHS Trust

10:00 BREAK

10:10 National Core Studies – Impact and future potential Chair: Professor Dame Anne Johnson, University College London Panellists: • Transmission and Environment: Professor Andrew Curran, Health and Safety Executive • Longitudinal Health and Wellbeing: Professor Jonathan Sterne, University of Bristol and HDR UK • Immunity: Professor Paul Moss, University of Birmingham • and Surveillance: Professor Sir Ian Diamond, UK National Statistician • Vaccines Trials Infrastructure: Divya Chadha Manek, National Institute for Health Research • Therapeutics Trials Infrastructure: Professor Patrick Chinnery, Medical Research Council • Data and Connectivity: Professor Andrew Morris, Health Data Research UK Q&A

11:05 BREAK 11:20 Lighting talks: Policy and societal impact of UK COVID science Chair: Professor Patrick Chinnery, Medical Research Council Panellists: Group 1 • ISARIC4C CCP-UK – lessons learned from >200k patients: Annemarie Docherty, University of Edinburgh • RECOVERY: The power of large simple trials: Dr Marion Mafham, University of Oxford • Single-cell multi-omics analysis of the immune response in COVID-19: Professor Muzlifah Haniffa, Newcastle University • Investigating ethnicity and COVID-19 using UK Biobank, ISARIC and other linked data sources: Dr Cameron Razieh, University of Leicester Q&A

Group 2 • Sequencing to understand SARS-CoV-2 transmission at regional and national scales: Dr Dinesh Aggarwal, COG-UK and • Immune responses to SARS-CoV-2 vaccination in the elderly: Dr Helen Parry, University of Birmingham • REACT-1: Symptoms predictive of COVID-19: Joshua Elliott, • Estimating COVID-19 vaccine effectiveness using OpenSAFELY: Dr William Hulme, University of Oxford

www.hdruk.ac.uk | [email protected] | @HDR_UK | www.healthdatagateway.org | www.ukhealthdata.org

Join the conversation: #COVIDcorestudies

Q&A 12:10 Preparing for the next pandemic Chair: Caroline Cake, Health Data Research UK Panellists: • Sir Menelas (Mene) Pangalos, AstraZeneca • Professor Gabriel Leung, The University of • Dr Lynda Stuart, Bill and Melinda Gates Foundation • Professor Kevin Fenton, Public Health England and NHS London 12:40 By everyone, for everyone: research and innovation for the future Professor Dame Ottoline Leyser, UK Research and Innovation 12:55 Closing remarks Dr Rob Orford, Chief Scientific Adviser for Health Wales

13:00 CLOSE

www.hdruk.ac.uk | [email protected] | @HDR_UK | www.healthdatagateway.org | www.ukhealthdata.org